About us

More than 30 years of experience in IVD (kits and instrumentation)

DIAsource ImmunoAssays S.A.(a BioVendor group company), an international diagnostic company based in Belgium, develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases.

We are committed to Vitamin D, including IVD and RUO Products. Our panel of assays allows the performant detection and measurement of various forms of Vitamin D metabolites : 25OH Vitamin D, 1,25(OH)2 Vitamin D.

Constantly looking for new technologies and applications, we put our expertise in the development of new antibodies and assays to measure relevant biomarkers. We are strengthening our position in the diagnostic market by validating our ELISA assays on our open automate. These innovation mark a turning point for our company, and makes of DIAsource, already renowned in the RIA market, a complete diagnostic provider.

We also provide selected instrumentation : we offer Elisa reader, washer and shaker, along with open and closed fully automated Elisa platforms helping our customers to automate their tests.

Present in more than 75 countries through his professional network of 80 distributors, DIAsource also sells directly his own products and products from other selected manufacturers to IVD laboratories in some European countries.

DIAsource ImmunoAssays SA, acquired, in September 2017, the full assets of Viro-Immun Diagnostics GmbH, the German company specialized in the development and manufacture of laboratory diagnostics for medical diagnosis of infectious and autoimmune diseases.

Beginning September 2017, Biovendor – Laboratorní medicína a.s. (BioVendor) acquired 100% of the shares of DIAsource ImmunoAssays SA from the Australian stock listed company Anteo Diagnostics (ASX: ADO).

For more information : http://www.diasource-diagnostics.com  

DIAsource Vitamin D Key Figures

  • 8 Vitamin D assays on the market (6 IVD and 2 RUO)
  • FDA approved 25OH Vitamin D Total ELISA
  • Double digit growth every year, >25% last year
  • >20 IVD partners including OEM and assay developers
  • Strong Vitamin D R&D pipeline
  • Combined team of highly skil
  • led and experienced chemists and biologists
  • Patented Monoclonal Antibodies (EP2316854, US2011097733)